Programme of Duchenne Awareness Day 2024


1300 ~ 1310 JST
0930 ~ 0940 IST
(0400 ~ 0410 GMT)


Dr. K. Raghavan.
Developmental Paediatrician & Neurologist.
Jesuit Antonyraj memorial Inter-disciplinary Centre for Advanced Recovery and Education (JAICARE), Madurai, India.
Welcome address and introduction.

1310 ~ 1400 JST
0940 ~ 1030 IST
(0410 ~ 0500 GMT)

Videocast of the lecture


Dr Yoshitsugu Aoki,
Director Molecular Therapy, National Centre for Neurology & Psychiatry, Tokyo, Japan .
Title: Oral administration of Neu-REFIX Beta 1,3-1,6 Glucans reduces skeletal muscle fibrosis and fatigue in dystrophic mice," delivered at the Joint Conference of the 22nd Annual Meeting of the Asian and Oceanian Myology Center and the 10th Annual Meeting of the Japan Muscle Society, Nara, Japan, on 14th September 2024.


1400 ~ 1445 JST
1030 ~ 1115 IST
(0500 ~ 0545 GMT)


Dr. K. Raghavan.
Developmental Paediatrician & Neurologist.
Jesuit Antonyraj memorial Inter-disciplinary Centre for Advanced Recovery and Education (JAICARE), Madurai, India.
Title: Summary of clinical trials on Neu-REFIX Beta 1,3-1,6 Glucans for Duchenne muscular dystrophy( DMD)



1445 ~ 1530 JST
1115 ~ 1200 IST
(0545 ~ 0630 GMT)

Expert comments from Panel

Panelists


Prof. Nobunao Ikewaki,
Dept. of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan.


Dr. Koji Ichiyama,
Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan


Dr. Samuel JK Abraham,
Centre for Advancing Clinical Research (CACR), University of Yamanashi-School of Medicine, Chuo, Japan & Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan.



Panel Discussion ; Q&A